Generic Diflucan (Fluconazole, Diflucan® equivalent)
Diflucan is a tablet you swallow to treat vaginal yeast infections caused by yeast called Candida. Diflucan is used to treat fungal infections, yeast infections, urinary tract infections, peritonitis, pneumonia, and cryptococcal infections. Diflucan is different from other treatments for vaginal yeast infections because it is a tablet taken by mouth. Do not take Diflucan, generic Diflucan, or Fluconazole if you are taking Cisapride.
This product will arrive to you in 14-24 business days (free shipping worldwide)
200mg
| Quantity | Price | Price per pill | Returning customer price | Bonus | |
|---|---|---|---|---|---|
| 10 | € 60.80 | € 6.08 | € 54.72 | ---- | Add to cart |
| 20 | € 82.84 | € 4.14 | € 74.48 | ---- | Add to cart |
| 30 | € 110.20 | € 3.67 | € 98.80 | ---- | Add to cart |
Drug Medical Information
AGE AND BEHAVIOR: INTELLIGENCE – CROSS-SECTIONAL AND LONGITUDINAL STUDIES - A COMMON BELIEF
There is a common belief that cross-sectional studies show decline in intellectual abilities in later life but that longitudinal studies do not. The fact is, such a belief is both overly simplistic and mainly wrong. There are two related reasons why this belief is prevalent. First, longitudinal studies tend to reflect lesser decline than cross-sectional studies, and they often show decline starting later in life. This is so largely, if not totally, because the initially less able are not as available for subsequent retesting as are the initially more able. This produces a biased sample at later longitudinal retests. As will be seen in more detail later, recent analysis showed that even when longitudinal research had indicated decline, continued longitudinal testing obfuscated the decline pattern seen previously because of the dropout of the initially less able people (Botwinick, 1977). The second reason why it is often believed that cross-sectional studies show decline and longitudinal studies do not has to do with the type of subjects dropping out of the longitudinal study and the type remaining in. A large number of the dropouts are people who had died in the course of the study, or people who had become ill. Riegel and Riegel (1972) suggested that if only the healthy survivors are considered, not the sick or deceased, decline is not observed. Age decline, this suggestion would have it, is observed only with those test-takers who are in the process of dying. Those in full health do not show decline. This may be true. But, with little exception, it is not possible to tell in advance who is to become sick or who is to die. Retrospective considerations make for highly artificial analyses; by definition, aging is living and dying, and this is part of longitudinal research. Longitudinal research provides information similar to cross-sectional research, at least insofar as intellectual performance is concerned. What differences are seen in the findings between the two methods of research are of magnitude, not type. As indicated, longitudinal research tends to reflect lesser decline, starting later in life. *263\220\8*
